KL-11743 is a small molecule inhibitor that disrupts glucose metabolism, leading to a rapid depletion of NADH and a marked increase in aspartate levels. This action forces a metabolic shift toward mitochondrial oxidative phosphorylation, making it a useful tool for studying cancer metabolism and bioenergetics in both cellular and animal models.